131 related articles for article (PubMed ID: 1104492)
1. Antibodies and antigen expression in human melanoma detected by the immune adherence test.
Cornain S; de Vries JE; Collard J; Vennegoor C; van Wingerden I; Rümke P
Int J Cancer; 1975 Dec; 16(6):981-97. PubMed ID: 1104492
[TBL] [Abstract][Full Text] [Related]
2. Membrane associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells.
Seibert E; Sorg C; Happle R; Macher E
Int J Cancer; 1977 Feb; 19(2):172-8. PubMed ID: 402317
[TBL] [Abstract][Full Text] [Related]
3. Serological survey of normal humans for natural antibody to cell surface antigens of melanoma.
Houghton AN; Taormina MC; Ikeda H; Watanabe T; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4260-4. PubMed ID: 6933476
[TBL] [Abstract][Full Text] [Related]
4. Studies of a melanoma tumor-associated antigen detected in the spent culture medium of a human melanoma cell line by allogeneic antibody. II. Immunobiologic characterization.
Gupta RK; Morton DL
J Natl Cancer Inst; 1984 Jan; 72(1):75-82. PubMed ID: 6582305
[TBL] [Abstract][Full Text] [Related]
5. Fluorescent antibody studies in malignant melanoma.
Whitehead RH
Br J Cancer; 1973 Dec; 28(6):525-9. PubMed ID: 4205845
[TBL] [Abstract][Full Text] [Related]
6. Serial determinations of melanoma tumor-associated antigen and antibody in patients with stage I melanoma.
Wong JH; Gupta RK; Morton DL
Arch Surg; 1986 Nov; 121(11):1342-5. PubMed ID: 3778209
[TBL] [Abstract][Full Text] [Related]
7. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells.
Leong SP; Sutherland CM; Krementz ET
Cancer Res; 1977 Nov; 37(11):4035-42. PubMed ID: 332343
[No Abstract] [Full Text] [Related]
8. Use of formalin-fixed melanoma cells for the detection of antibodies against surface antigens by a micro-immune adherence technique.
Müller C; Sorg C
Eur J Immunol; 1975 Mar; 5(3):175-8. PubMed ID: 1234054
[TBL] [Abstract][Full Text] [Related]
9. Rheumatoid factor in melanoma patients: alterations of humoral tumor immunity in vitro.
Giuliano AE; Irie R; Morton DL
Cancer; 1979 May; 43(5):1624-9. PubMed ID: 376097
[TBL] [Abstract][Full Text] [Related]
10. The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines.
Livingston PO; Kaelin K; Pinsky CM; Oettgen HF; Old LJ
Cancer; 1985 Nov; 56(9):2194-200. PubMed ID: 4052966
[TBL] [Abstract][Full Text] [Related]
11. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
Gupta RK; Silver HK; Reisfeld RA; Morton DL
Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
[TBL] [Abstract][Full Text] [Related]
12. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.
Shiku H; Takahashi T; Oettgen HF
J Exp Med; 1976 Oct; 144(4):873-81. PubMed ID: 978138
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the techniques used for monitoring humoral immunity in cancer patients.
Renk CM; Gupta RK; Irie RF; Morton DL
J Surg Oncol; 1982 Mar; 19(3):155-61. PubMed ID: 7040819
[TBL] [Abstract][Full Text] [Related]
14. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
[TBL] [Abstract][Full Text] [Related]
15. Studies of humoral and cell-mediated immunity in human melanoma.
Mukherji B; Nathanson L; Clark DA
Yale J Biol Med; 1973 Dec; 46(5):681-92. PubMed ID: 4130586
[No Abstract] [Full Text] [Related]
16. Demonstration of a well-characterized tumor-associated antigen on melanoma cell surface.
Wong JH; Gupta RK; Morton DL
J Surg Oncol; 1988 Jul; 38(3):147-50. PubMed ID: 3292843
[TBL] [Abstract][Full Text] [Related]
17. Immunofluorescent studies of the serologic reactivity of patients with malignant melanoma against tumor-associated cytoplasmic antigens.
Wood GW; Barth RF
J Natl Cancer Inst; 1974 Aug; 53(2):309-16. PubMed ID: 4602060
[No Abstract] [Full Text] [Related]
18. In-vitro interactions between antitumour antibodies and anti-antibodies in malignancy.
Hartmann D; Lewis MG; Proctor JW; Lyons H
Lancet; 1974 Dec; 2(7895):1481-3. PubMed ID: 4140396
[No Abstract] [Full Text] [Related]
19. Surface antigens on cultured malignant melanoma cells as detected by a membrane immunofluorescence method with human sera. Lack of tumor-specific reactions on melanoma lines.
The TH; Huiges HA; Schraffordt Koops H; Lamberts HB; Nieweg HO
Ann N Y Acad Sci; 1975 Jun; 254():528-40. PubMed ID: 1101782
[TBL] [Abstract][Full Text] [Related]
20. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen.
Jones PC; Sze LL; Liu PY; Morton DL; Irie RF
J Natl Cancer Inst; 1981 Feb; 66(2):249-54. PubMed ID: 6935475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
